Trademark: 97057483
Word

Status
Registered
Status Code
700
Status Date
Tuesday, November 8, 2022
Serial Number
97057483
Registration Number
6897161
Registration Date
Tuesday, November 8, 2022
Mark Type
2000
Filing Date
Sunday, October 3, 2021
Published for Opposition
Tuesday, January 25, 2022

Trademark Owner History
Alnylam Pharmaceuticals, Inc. - Original Registrant

Classifications
5 Pharmaceutical preparations for the treatment of amyloidosis
The mark consists of the design of a stylized double helix.

Trademark Events
Nov 8, 2022
Notice Of Registration Confirmation Emailed
Nov 8, 2022
Registered-Principal Register
Oct 1, 2022
Notice Of Acceptance Of Statement Of Use E-Mailed
Sep 30, 2022
Allowed Principal Register - Sou Accepted
Aug 1, 2022
Statement Of Use Processing Complete
Jul 15, 2022
Use Amendment Filed
Aug 1, 2022
Case Assigned To Intent To Use Paralegal
Jul 15, 2022
Teas Statement Of Use Received
Jul 15, 2022
Teas Change Of Correspondence Received
Jul 15, 2022
Teas Withdrawal Of Attorney Received-Firm Retains
Jul 15, 2022
Attorney/Dom.Rep.Revoked And/Or Appointed
Jul 15, 2022
Teas Revoke/App/Change Addr Of Atty/Dom Rep Received
Mar 22, 2022
Noa E-Mailed - Sou Required From Applicant
Jan 25, 2022
Official Gazette Publication Confirmation E-Mailed
Jan 25, 2022
Published For Opposition
Jan 5, 2022
Notification Of Notice Of Publication E-Mailed
Dec 18, 2021
Approved For Pub - Principal Register
Dec 18, 2021
Assigned To Examiner
Oct 30, 2021
Notice Of Design Search Code E-Mailed
Oct 29, 2021
New Application Office Supplied Data Entered In Tram
Oct 6, 2021
New Application Entered In Tram

Trademark Alertz updated from USPTO on 2030-01-24